Access personalized Immunotherapy care using advanced medical technology, supported by expert specialists and dedicated international patient services.
Choosing BLK-Max Super Speciality Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 1959, the JCI, NABH accredited hospital is located in Delhi, India and operates 650 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
